Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122512252 | 12251225 | 2 | F | 2004 | 20160623 | 20160410 | 20160711 | PER | US-JNJFOC-20160318365 | JANSSEN | 0.00 | M | Y | 0.00000 | 20160711 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122512252 | 12251225 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 0.5 - 0.75 MG | U | U | 0 | UNSPECIFIED | |||||||
122512252 | 12251225 | 2 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | 0.5 - 0.75 MG | U | U | 20272 | UNSPECIFIED | |||||||
122512252 | 12251225 | 3 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | 117 - 234 MG | U | U | 0 | INJECTION | |||||||
122512252 | 12251225 | 4 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | 117 - 234 MG | U | U | 0 | INJECTION | |||||||
122512252 | 12251225 | 5 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | 117 - 234 MG | U | U | 22264 | INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122512252 | 12251225 | 1 | Depression |
122512252 | 12251225 | 2 | Anger |
122512252 | 12251225 | 3 | Bipolar disorder |
122512252 | 12251225 | 4 | Depression |
122512252 | 12251225 | 5 | Anger |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122512252 | 12251225 | Abnormal weight gain | |
122512252 | 12251225 | Galactorrhoea | |
122512252 | 12251225 | Gynaecomastia | |
122512252 | 12251225 | Off label use | |
122512252 | 12251225 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122512252 | 12251225 | 1 | 2004 | 2006 | 0 | |
122512252 | 12251225 | 2 | 2004 | 2006 | 0 | |
122512252 | 12251225 | 3 | 2013 | 2014 | 0 | |
122512252 | 12251225 | 4 | 2013 | 2014 | 0 | |
122512252 | 12251225 | 5 | 2013 | 2014 | 0 |